termin
sialic
acid
cell
surfac
glycoconjug
carri
acetyl
ester
technic
reason
previous
difficult
determin
precis
distribut
differ
cell
type
use
recombin
solubl
form
influenza
c
viru
hemagglutininesteras
probe
acetyl
sialic
acid
demonstr
preferenti
express
cell
lineag
normal
mous
lymphoid
organ
total
thymocyt
carri
acetyl
great
major
matur
pna
hsa
tcr
hi
medullari
cell
low
level
acetyl
seen
doubl
posit
dp
singl
posit
sp
cell
high
level
present
primarili
sp
cell
correl
level
suggest
acetyl
appear
earli
differenti
marker
cell
matur
dp
sp
phenotyp
high
degre
acetyl
also
present
peripher
spleen
lymph
node
cell
contrast
small
minor
cell
b
cell
show
level
acetyl
among
matur
peripher
lymphocyt
highli
acetyl
cell
mel
hi
lo
exon
b
hi
featur
typic
naiv
cell
digest
trypsin
sialoglycoproteas
osgpas
elisa
studi
lipid
extract
indic
acetyl
sialic
acid
peripher
cell
predominantli
olink
mucintyp
glycoprotein
lesser
degre
sialyl
glycolipid
gangliosid
contrast
sialic
acid
mucin
type
molecul
cell
acetyl
instead
molecul
mask
recognit
acetyl
gangliosid
seem
present
similar
level
cell
acetyl
gangliosid
mous
cell
bound
antibodi
recogn
acetyl
gangliosid
human
cell
tether
acetyl
mucin
influenza
c
probe
without
secondari
crosslink
caus
activ
cell
howev
activ
stimuli
includ
tcr
ligat
associ
substanti
decreas
surfac
acetyl
primarili
mucin
glycoprotein
compon
thu
acetyl
sialic
acid
cell
surfac
mucin
novel
marker
cell
appear
matur
modul
downward
upon
activ
ialic
acid
sia
famili
neg
charg
sugar
usual
found
termin
posit
mammalian
cell
surfac
sugar
chain
sia
attach
underli
glycoconjug
varieti
linkag
modifi
mani
differ
way
modif
thought
rare
speciesspecif
curios
howev
recent
evid
shown
modif
wide
distribut
previous
thought
exampl
sia
often
carri
acetyl
substitut
posit
sinc
acetyl
ester
posit
spontan
migrat
posit
physiolog
extracellular
ph
acetyl
sia
predomin
cell
surfac
glycoconjug
identif
cell
sialoglycoconjug
bear
technic
challeng
sinc
ester
often
present
fraction
total
sialic
acid
biochem
purif
step
accompani
vari
loss
acetyl
sever
studi
shown
acetyl
affect
biolog
properti
underli
molecul
ester
commonli
seen
cell
neuroectod
abbrevi
use
paper
bm
bone
marrow
che
influenza
c
viru
hemagglutininesteras
protein
fusion
peptid
elimin
mutat
chefc
chimer
protein
made
che
fc
portion
human
igg
chefcd
dfp
treat
chefc
esteras
activ
irrevers
inactiv
dfp
diisopropylfluorophosph
dn
doubl
neg
dp
doubl
posit
hsa
heat
stabl
antigen
osgpas
osialoglycoproteas
pna
peanut
agglutinin
sia
sialic
acid
sp
singl
posit
tb
trisbuff
salin
acetyl
cell
mal
origin
seem
role
migrat
develop
neuron
embryon
brain
abrog
acetyl
deleteri
affect
develop
transgen
mice
modif
also
involv
specif
recognit
cell
influenza
c
viru
coronavirus
modul
activ
complement
altern
pathway
mask
ligand
ityp
lectin
mediat
cell
adhes
via
sialyl
ligand
eg
b
cell
sialoadhesin
tissu
macrophag
take
advantag
bind
catalyt
properti
influenza
c
virion
hemagglutininesteras
che
protein
acetyl
sialic
acid
earlier
engin
recombin
solubl
form
extracellular
domain
che
chefc
human
igg
fc
region
fuse
carboxyl
end
treatment
molecul
diisopropylfluorophosph
dfp
select
abrog
esteras
activ
chefcd
preserv
bind
properti
thu
probe
bifunct
tool
either
select
remov
chefc
specif
detect
chefcd
acetyl
ester
studi
mous
peripher
leukocyt
probe
note
high
bind
cell
much
less
bind
cell
apart
molecul
unawar
cell
surfac
marker
select
express
cell
comparison
cell
therefor
decid
delin
presenc
distribut
acetyl
sialic
acid
cell
murin
cell
lineag
inde
find
acetyl
sialic
acid
novel
cell
surfac
marker
appear
differenti
singl
posit
cell
thymu
persist
high
level
cell
peripheri
decreas
express
upon
cellular
activ
also
use
enzym
trypsin
osialoglycoproteas
osgpas
explor
distribut
modifi
sialic
acid
differ
class
glycoconjug
found
cell
surfac
latter
enzym
particularli
use
select
cleav
mucintyp
glycoprotein
cluster
sialyl
olink
sugar
chain
form
mice
mice
purchas
jackson
laboratori
bar
harbor
studi
done
freshli
isol
cell
wk
old
mice
antibodi
probe
fluorescein
antihuman
igg
secondari
antibodi
use
detect
bind
chefcd
probe
cell
fitc
phycoerythrin
tricolor
conjug
rat
monoclon
antibodi
murin
purchas
caltag
laboratori
san
francisco
ca
bind
biotinyl
rat
monoclon
antibodi
pharmingen
san
diego
ca
murin
mel
detect
use
appropri
conjug
streptavidin
flow
cytometr
assay
monoclon
antibodi
recogn
isoform
clone
anti
monoclon
antibodi
use
fac
stain
western
blot
bind
antibodi
protein
western
blot
detect
use
neutravidinalkalin
phosphatas
conjug
purchas
pierc
rockford
illinoi
antimous
hamster
hybridoma
prepar
ascit
form
use
stain
cell
express
tcr
rat
antimous
heat
stabl
antigen
hsa
use
cultur
supernat
hybridoma
jone
antibodi
mous
igm
recogn
acetyl
g
purchas
sigma
chem
co
st
loui
mo
mous
igg
specif
jone
obtain
cell
cultur
supernat
hybridoma
provid
farquhar
ucsd
solubl
chimer
protein
chefc
consist
extracellular
domain
influenza
c
hemagglutininesteras
fuse
fc
portion
human
igg
gener
character
describ
modifi
form
chefcd
gener
treat
chefc
mm
dfp
inactiv
esteras
activ
describ
chefc
specif
releas
acetyl
ester
sia
ie
function
esteras
wherea
chefcd
specif
recogn
bind
acetyl
sia
fluorescein
peanut
agglutinin
lectin
pna
obtain
ey
laboratori
inc
san
mateo
ca
flow
cytometr
analysi
cell
express
cell
surfac
acetyl
sialic
acid
examin
flow
cytometr
analysi
facscan
machin
freshli
obtain
live
cell
mous
thymu
lymph
node
spleen
prepar
hypoton
lysi
rbc
cell
wash
suspend
ice
cold
pb
bovin
serum
albumin
sodium
azid
stain
buffer
chefcd
probe
allow
bind
cell
immunocomplex
fitc
phycoerythrin
conjug
goat
antihuman
secondari
antibodi
chefcd
g
incub
dilut
secondari
antibodi
c
overnight
precomplex
step
increas
overal
avid
probe
toward
acetyl
sialic
acid
chefcd
antihuman
igg
fc
immunocomplex
allow
bind
cell
h
ice
doubl
triplecolor
stain
chefcd
probe
allow
bind
cell
stain
remain
antibodi
min
room
temperatur
chefc
use
ident
condit
neg
control
chefcd
bind
studi
cell
deo
acetyl
stain
chefc
use
final
concentr
gml
volum
l
stain
buffer
contain
cell
incub
c
h
trypsin
cell
incub
trypsin
mm
edta
hank
balanc
salt
solut
h
c
water
bath
wash
twice
cold
pb
stain
loss
bind
use
confirm
trypsin
activ
treatment
osgpas
cedarlan
laboratori
ltd
ontario
canada
live
cell
l
stain
buffer
incub
l
reconstitut
enzym
c
h
cell
wash
twice
cold
pb
stain
decreas
chefcd
bind
murin
erythroleukemia
cell
follow
osgpas
treatment
use
posit
control
enzym
data
shown
follow
stain
cell
wash
excess
stain
buffer
fix
pb
contain
formaldehyd
fix
buffer
stain
fix
cell
kept
dark
c
analyz
flow
cytometri
day
purif
cell
fresh
mous
lymphocyt
either
spleen
lymph
node
prepar
hypoton
lysi
rbc
separ
dead
cell
ficol
hypaqu
densiti
centrifug
cell
stain
rat
antimous
conjug
magnet
bead
miltenyi
biotec
inc
auburn
ca
antibodi
use
final
dilut
stain
million
live
cell
volum
l
ice
min
cell
separ
use
magnet
cell
sorter
mac
puriti
sort
popul
confirm
flow
cytometri
case
cell
separ
becton
dickinson
facsort
stain
tricolor
conjug
rat
antimous
activ
cell
either
total
cell
facsort
cell
mous
lymph
node
activ
ehaa
medium
gibco
brl
gaithersburg
md
supplement
heat
inactiv
fb
l
glutamin
penicillin
streptomycin
mm
hepe
refer
hereaft
ehaa
growth
medium
c
humidifi
atmospher
co
presenc
ng
per
ml
pma
nm
ionomycin
typic
cell
cultur
ml
medium
per
well
plate
aliquot
cell
analyz
flow
cytometri
level
express
acetyl
subsequ
day
experi
either
total
lymph
node
cell
cell
mix
mitomycintr
syngen
mous
spleen
cell
l
ehaa
growth
medium
place
plate
coat
ng
mab
crosslink
tcr
complex
activ
cell
studi
check
chefcd
induc
activ
chefcd
probe
amount
rang
g
allow
bind
overnight
c
staph
protein
acoat
plate
lymphocyt
peripher
lymph
node
incub
l
ehaa
growth
medium
per
coat
well
triplic
well
set
amount
chefcd
ident
setup
chefc
done
neg
control
later
cell
puls
ciwel
h
thymidin
follow
day
cell
harvest
onto
glass
fiber
filtermat
amount
incorpor
radioact
determin
betapl
reader
wallac
wallac
inc
gaithersburg
md
crosslink
describ
done
posit
control
anoth
set
experi
chefcd
allow
bind
cell
solut
without
crosslink
ligand
assay
done
triplic
amount
chefcd
flat
bottom
plate
purifi
cell
mitomycintr
syngen
mous
splenic
cell
ad
l
ehaa
growth
medium
per
well
final
concentr
chefcd
well
vari
gml
similar
amount
chefc
use
neg
control
see
whether
chefcd
bind
cell
either
potenti
diminish
respons
activ
stimuli
cell
stimul
pharmacolog
use
pma
crosslink
tcr
antibodi
stimul
carri
use
increas
dose
stimul
agent
rang
gave
concomit
increas
activ
chefc
chefcd
gml
final
use
combin
vari
amount
pma
compar
cell
activ
absenc
chefc
chefcd
cell
incub
puls
ciwel
h
thymidin
incorpor
radioact
quantit
describ
earlier
extract
glycoprotein
glycolipid
membran
protein
prepar
spleen
lymph
node
cell
remain
hypoton
lysi
red
blood
cell
cell
wash
pb
three
time
follow
hypoton
lysi
presenc
mm
hepe
ph
cocktail
proteas
inhibitor
disrupt
nitrogen
cavit
spun
g
remov
nuclei
unbroken
cell
cloudi
supernat
spun
g
obtain
total
membran
pellet
membran
extract
triton
trisbuff
salin
ph
tb
separ
membran
debri
recentrifug
g
protein
concentr
determin
bradford
assay
typic
g
membran
protein
could
obtain
cell
adjust
gl
use
western
blot
immunoprecipit
assay
purifi
gangliosid
wash
cell
pellet
sequenti
extract
vol
chcl
meoh
volvol
use
brief
homogen
extract
pool
dri
brought
chcl
meohwat
ratio
phase
separ
gangliosid
enrich
hydophil
upper
phase
dri
resuspend
methanol
kept
use
elisa
plate
assay
gangliosid
total
gangliosid
extract
prepar
studi
lipid
elisa
describ
previous
brief
lipid
appli
plate
methanol
allow
dri
block
bsa
pb
overnight
effect
base
deoacetyl
reactiv
assess
treatment
naoh
min
condit
caus
loss
bound
gangliosid
treatment
plate
extens
wash
pb
block
bsa
pb
h
incub
chefcd
gml
h
wash
three
time
bsa
horseradish
peroxidaseconjug
goat
antimous
igg
ad
dilut
h
wash
reaction
develop
describ
background
level
determin
secondari
antibodi
alon
subtract
western
blot
assay
membran
protein
extract
describ
total
lymphocyt
harvest
mous
spleen
lymph
node
sdspage
done
reduc
condit
gel
electrophores
materi
transfer
nitrocellulos
membran
block
bovin
serum
albumin
tb
h
room
temperatur
incub
primari
probe
overnight
rock
platform
chefcd
use
concentr
gml
biotinyl
monoclon
isoform
use
concentr
gml
tb
contain
bovin
serum
albumin
membran
wash
thrice
tween
tb
min
incub
secondari
reagent
h
room
temperatur
bound
biotinyl
antibodi
detect
dilut
neutravidinalkalin
phosphatas
pierc
chem
co
rockford
il
chefcd
bind
assay
dilut
goat
antihuman
fc
conjug
alkalin
phosphatas
biorad
richmond
ca
membran
wash
thrice
tween
tb
min
tb
put
alkalin
phosphatas
buffer
ph
ad
substrat
nbtbcip
dilut
reaction
allow
progress
min
wash
water
dri
select
precipit
glycoprotein
membran
extract
g
membran
protein
extract
first
preclear
protein
asepharos
bead
end
end
roll
h
meanwhil
g
chefcd
allow
complex
l
protein
asepharos
end
end
roll
length
time
whole
mixtur
incub
overnight
preclear
sampl
volum
l
end
end
roll
bead
spun
wash
tb
ph
success
boil
sd
sampl
buffer
elut
protein
load
sdspage
gel
probe
monoclon
describ
chefc
molecul
serv
neg
control
protein
specif
bound
chefcd
immunoprecipit
also
reprob
chefcd
confirm
reactiv
check
percentag
total
protein
precipit
thymocyt
flow
cytometri
analysi
dispers
thymocyt
chefcd
stain
show
surfac
fig
middl
posit
stain
cell
heterogen
respect
degre
rang
log
fluoresc
intens
doublecolor
analysi
pna
chefcd
show
almost
posit
cell
matur
pna
phenotyp
expect
medullari
thymocyt
fig
b
fit
previou
studi
stain
murin
thymu
section
chefcd
probe
note
predominantli
medullari
region
specif
chefcd
stain
confirm
markedli
lower
bind
chefc
fig
left
residu
stain
probabl
cell
high
give
weak
signal
even
esteraseact
probe
final
bind
chefcd
substanti
abrog
cell
treat
chefc
esteras
stain
fig
right
subsequ
studi
chefc
control
routin
done
result
show
cell
surfac
predominantli
matur
popul
murin
thymocyt
degre
thymocyt
rang
log
scale
fluoresc
intens
fig
middl
notic
total
percentag
chefcd
thymocyt
tend
correl
best
percentag
singl
posit
sp
cell
prepar
inde
upon
threecolor
analysi
cell
larg
fraction
found
sp
cell
fig
contrast
high
intens
stain
sp
cell
degre
low
cell
type
except
enrich
doubl
neg
dn
cell
analys
show
present
sp
cell
dn
cell
sp
cell
fig
densiti
dn
cell
rel
lower
sp
cell
fig
given
heterogen
dn
thymocyt
respect
matur
certain
subpopul
cell
regardless
lowest
amount
seen
doubl
posit
dp
thymocyt
thereaft
progress
increas
tion
cell
matur
dp
stage
sp
stage
contrast
cell
progress
toward
lineag
show
minim
increas
cell
sp
subset
vari
level
level
correl
invers
level
fig
thu
increas
cell
surfac
correl
progress
matur
thymocyt
associ
phenotyp
thymocyt
marker
lineag
thymocyt
select
gate
studi
relationship
well
defin
trait
mark
progress
cell
dp
stage
fig
increas
correl
increas
express
tcr
decreas
level
hsa
indic
cell
commit
matur
dp
stage
thymocyt
matur
sp
stage
occur
upregul
respons
signal
deliv
tcr
posit
select
increas
express
remain
stabl
earli
cell
activ
marker
initi
high
hi
lo
stage
decreas
lower
level
sp
cell
transit
cell
dp
sp
stage
almost
sp
cell
hi
phenotyp
fit
observ
cell
also
hi
fig
lo
lo
cell
probabl
transit
cell
although
hi
cell
cell
whole
appear
equal
divid
respect
express
impli
identifi
cell
pure
base
activ
state
togeth
result
show
thymocyt
major
carrier
express
progress
increas
matur
thymu
organ
vari
level
found
lymphocyt
spleen
lymph
node
differ
prepar
spleen
lymph
node
percentag
cell
vari
although
lymphocyt
lymphocyt
also
phenotyp
de
lo
exonb
hi
fig
inde
cell
phenotyp
almost
indic
high
marker
naiv
cell
phenotyp
distribut
cell
surfac
among
glycoprotein
glycolipid
trypsin
thymocyt
caus
partial
loss
posit
cell
fig
bottom
likewis
fac
sort
sp
cell
trypsintr
signific
decreas
nearli
fivefold
decreas
mean
fluoresc
intens
glycoprotein
expect
trypsin
sensit
trypsinresist
glycoconjug
like
sialyl
glycolipid
gangliosid
one
import
subset
cell
surfac
glycoprotein
mucin
cluster
sialyl
olink
oligosaccharid
includ
isoform
select
elimin
enzym
osgpas
endopeptidas
cleav
mucin
upon
treatment
thymocyt
osgpas
fig
middl
mark
decreas
nearli
fivefold
decreas
mean
fluoresc
intens
indic
mani
group
sia
attach
olink
oligosaccharid
mucintyp
glycoprotein
murin
erythroleukemia
cell
serv
posit
control
enzym
data
shown
substanti
loss
high
sp
cell
osgpas
treatment
indic
mucintyp
glycoprotein
major
carrier
cell
similar
trypsin
osgpas
treatment
done
purifi
peripher
cell
spleen
lymph
node
also
indic
glycoprotein
olink
mucintyp
fig
b
left
show
antihsa
third
color
bind
mab
detect
use
phycoerythrinconjug
goat
antihamst
igg
mab
detect
fitc
conjug
donkey
antirat
igg
directli
conjug
fitc
tricolor
reagent
thymocyt
gate
show
dot
plot
relat
thymocyt
marker
quadrant
boundari
determin
base
background
stain
profil
obtain
secondari
antibodi
axi
ing
threeto
fivefold
decreas
mean
fluoresc
intens
stain
enzym
treatment
howev
also
signific
amount
trypsinand
osgpaseresist
fig
b
left
inde
shift
profil
upon
proteas
digest
indic
almost
cell
glycoprotein
may
also
gangliosid
notabl
molecul
preserv
treatment
osgpas
despit
fact
carri
sever
scatter
olink
oligosaccharid
data
shown
provid
intern
control
select
enzym
cleav
mucintyp
protein
mani
cluster
sialyl
olink
chain
confirm
residu
stain
proteas
digest
due
gangliosid
elisa
assay
chefcd
probe
done
lipid
extract
obtain
cell
bind
probe
lipid
plate
abrog
base
treatment
indic
presenc
gangliosid
extract
fig
one
better
studi
gangliosid
g
recent
shown
occur
human
peripher
cell
one
epitop
cluster
molecul
detect
mous
thymocyt
mous
peripher
cell
use
jone
antibodi
data
shown
howev
antibodi
highli
specif
g
would
detect
mani
gangliosid
therefor
tri
mab
recogn
certain
larger
gangliosid
human
melanoma
cell
antibodi
also
unabl
bind
mous
thymocyt
peripher
cell
data
shown
also
correl
presenc
absenc
epitop
recogn
antibodi
known
detect
mous
cell
gangliosid
g
data
shown
data
suggest
certain
gangliosid
murin
cell
constitut
signific
proport
total
molecul
must
structur
distinct
report
marker
human
cell
effect
cell
activ
cell
surfac
matur
cell
lymph
node
purifi
activ
pmaionomycin
activ
phenotyp
confirm
look
cell
surfac
activ
marker
variou
day
activ
rang
day
day
cell
surfac
show
nearli
twoto
threefold
decreas
day
fig
b
right
residu
follow
activ
almost
entir
refractori
treatment
trypsin
osgpas
fig
b
right
indic
lost
mucintyp
protein
gangliosid
confirm
direct
analysi
gangliosid
activ
cell
fig
correl
express
exonb
day
activ
data
shown
thu
sialic
acid
mucintyp
glycoprotein
appear
distinct
marker
cell
downregul
upon
activ
contrast
gangliosid
persist
activ
ligat
group
cell
caus
activ
antibodi
report
weakli
mitogen
human
peripher
blood
mononuclear
cell
comitogen
phorbol
ester
pma
purifi
rest
cell
although
murin
lymphocyt
group
ligat
chefcd
lymphocyt
murin
lymph
node
cultur
plate
precoat
protein
asepharos
coat
increas
amount
chefcd
crosslink
molecul
cell
surfac
result
prolifer
cell
follow
next
day
data
shown
also
prolifer
equival
amount
chefc
irrelev
chimera
likewis
also
prolif
respons
purifi
cell
chefcd
use
solubl
form
presenc
mitomycin
treat
costimulatori
cell
data
shown
fig
top
figur
associ
marker
among
peripher
lymphocyt
flow
cytometri
done
three
color
stain
use
chefcd
along
exonb
peripher
cell
marker
use
biotinyl
antibodi
bind
detect
use
streptavidin
conjug
fitc
data
display
repres
gate
cell
stain
axi
dot
plot
determin
use
secondari
fluoresc
conjug
reagent
alon
without
primari
antibodi
probe
level
detect
matur
cell
consider
lower
cell
consid
possibl
might
due
differenti
express
sialyl
substrat
respect
cell
type
given
preponder
sialomucin
cell
look
presenc
cell
shown
fig
remov
sialomucin
osgpas
actual
give
increas
chefcd
bind
cell
ie
opposit
result
cell
result
confirm
treat
cell
trypsin
fig
combin
trypsin
follow
osgpas
data
shown
indic
detect
proteas
resist
gangliosid
mask
presenc
sialomucin
cell
pattern
increas
chefcd
bind
trypsin
osgpas
treatment
also
reproduc
sp
thymocyt
fig
b
result
demonstr
presenc
sialomucin
cell
indic
unlik
cell
molecul
substrat
exonb
isoform
repres
mucin
leukosialin
two
major
wellcharacter
cell
surfac
glycoprotein
known
carri
larg
amount
olink
oligosaccharid
termin
sialic
acid
assum
might
mucinlik
molecul
carri
andor
mask
chefcd
bind
gangliosid
look
differ
level
cell
thymic
peripher
cell
express
high
molecular
weight
isoform
exon
code
rb
specifi
isoform
rel
predomi
figur
chang
cell
surfac
trypsin
osgpas
treatment
activ
thymocyt
treat
trypsin
osgpas
wash
stain
follow
osgpas
treatment
sp
cell
gate
dot
plot
examin
chefcd
stain
profil
stain
unchang
osgpas
treatment
data
shown
studi
effect
trypsin
chefcd
bind
sp
cell
sp
thymocyt
first
facsort
twocolor
stain
antibodi
prior
chefcd
stain
b
cell
peripher
lymph
node
purifi
facsort
treat
trypsin
osgpas
wash
stain
left
one
aliquot
cell
activ
crosslink
plate
profil
display
right
panel
repres
gate
cell
third
day
activ
similar
pattern
seen
thereaft
data
shown
case
percentag
posit
cell
shown
within
histogram
display
background
level
stain
repres
dash
line
nant
compar
ra
rc
specifi
isoform
amongst
variou
antibodi
recogn
isoform
clone
shown
better
bind
splenic
cell
sinc
cell
focus
chose
antibodi
fac
western
blot
studi
conced
fact
antibodi
would
specif
major
subset
isoform
fig
show
exon
b
code
isoform
sialomucin
sinc
osgpas
treatment
cell
surfac
almost
complet
destroy
bind
respect
antibodi
confirm
western
blot
analysi
cell
membran
protein
extract
treat
without
osgpas
use
antibodi
data
shown
result
agreement
earlier
report
use
method
western
blot
andor
fac
analysi
describ
loss
recognit
osgpas
treatment
epitop
oglycanas
osgpas
digest
evalu
mean
fluoresc
intens
stain
vari
dilut
antibodi
express
cell
surfac
glycoprotein
actual
show
higher
level
exonb
contain
isoform
cell
cell
data
shown
observ
consist
earlier
result
use
clone
data
fig
show
rel
abund
glycoprotein
cell
comparison
cell
satur
level
antibodi
thu
differ
sialomucin
due
differ
level
express
parent
molecul
cell
western
blot
analys
membran
protein
isol
total
splenic
mononuclear
cell
chefcd
probe
reveal
sever
high
molecular
mass
protein
fig
specif
recognit
confirm
absenc
bind
chefc
similar
concentr
data
shown
preincub
protein
osgpas
destroy
posit
band
confirm
sialomucin
major
glycoprotein
cell
two
major
band
coincid
molecular
mass
expect
evalu
matter
glycoprotein
precipit
total
membran
protein
extract
use
chefcd
bound
protein
asepharos
via
human
igg
fc
tail
chefc
protein
use
control
nonspecif
precipit
bound
protein
separ
reduc
sdspage
gel
transfer
nitrocellulos
membran
probe
monoclon
antibodi
recognis
exon
b
isoform
fig
demonstr
protein
precipit
chefcd
includ
molecul
recogn
comigr
posit
band
total
membran
protein
recogn
antibodi
weaker
intens
band
reflect
lower
amount
give
expect
band
kd
weaker
band
detect
band
migrat
slightli
bulk
popul
molecul
might
due
differenti
mobil
differ
glycoform
bright
band
seen
kd
probe
nonspecif
sinc
present
blot
probe
alkalinephosphatas
conjug
neutravidin
alon
also
probe
data
shown
upon
probe
materi
precipit
chefcd
compar
profil
chefcd
western
blot
untreat
total
protein
extract
clear
glycoprotein
precipit
data
shown
may
due
fact
singl
round
deplet
done
due
differenti
affin
chefcd
variou
protein
regardless
evid
data
exonb
among
cell
surfac
mucin
ligand
earlier
studi
lab
show
sialic
acid
could
mask
bind
recombin
solubl
ligand
cell
murin
lymphoid
organ
found
high
amount
ligand
peripher
cell
sp
thymocyt
lower
amount
immatur
thymocyt
flow
cytometri
data
shown
treatment
chefc
significantli
increas
bind
either
matur
peripher
cell
sp
thymocyt
data
shown
result
consist
fact
glycoprotein
cell
mucin
type
olink
structur
unlik
carri
sia
glcnac
sequenc
typic
ligand
mous
spleen
cell
stain
chefcd
osgpas
trypsin
treatment
stain
profil
trace
gate
subpopul
trypsin
treatment
done
cell
presort
facsort
loss
bind
posit
control
trypsin
data
shown
b
mous
thymocyt
treat
osgpas
describ
earlier
wash
stain
chefcd
sham
treat
cell
incub
equal
volum
buffer
ident
condit
live
event
acquir
sp
cell
gate
dot
plot
chefcd
bind
within
popul
plot
histogram
dot
line
show
background
stain
second
antibodi
figur
sialomucin
express
cell
cell
freshli
isol
mous
splenic
lymphocyt
incub
osgpas
buffer
alon
ident
condit
follow
threecolor
stain
either
dilut
gml
mean
fluoresc
intens
stain
gate
popul
cell
determin
facscan
type
cell
uniqu
surfac
signatur
determin
glycosyl
molecul
sialic
acid
differ
linkag
underli
glycoconjug
confer
fair
degre
divers
modif
sialic
acid
enhanc
divers
recent
sialic
acid
consid
rare
odditi
among
plethora
glycosyl
structur
found
mammalian
system
known
occur
sever
tissu
neuroectoderm
mesenchym
descent
studi
situ
histochemistri
use
specif
probe
indic
tempor
spatial
pattern
regul
develop
tissu
given
cell
type
tend
nonrandomli
distribut
respect
type
cell
surfac
glycoconjug
well
regard
type
sialic
acid
linkag
given
glycoconjug
data
suggest
specif
role
modif
cellcel
recognit
event
inher
tissu
organ
andor
develop
descript
base
chemic
analys
bind
certain
highli
specif
monoclon
antibodi
also
recogn
detail
underli
molecul
earlier
studi
show
indirect
method
mous
thymocyt
might
sialic
acid
also
report
cell
patient
variou
malign
oacetyl
sialic
acid
present
pig
lymphocyt
howev
extract
method
use
could
specif
distinguish
cell
surfac
assay
involv
use
intact
influenza
c
virion
specif
recogn
sialic
acid
approach
limit
puriti
stabil
viru
prepar
rel
high
background
avail
solubl
recombin
chimera
chefcd
deriv
influenza
c
versatil
varieti
vitro
assay
make
possibl
look
cell
surfac
irrespect
underli
sugar
structur
studi
cell
surfac
express
sialic
acid
intact
fresh
lymphocyt
isol
normal
mice
b
lymphocyt
lymphocyt
heterogen
express
low
level
sialic
acid
singular
pattern
high
densiti
express
cell
led
current
set
investig
earlier
work
lab
chefcd
stain
note
medullari
region
histolog
section
thymu
keep
show
acquisit
phenotyp
occur
almost
entir
within
subset
pna
matur
thymocyt
low
percentag
thymocyt
posit
yet
highli
heterogen
cell
surfac
densiti
disproportion
higher
percentag
sp
cell
dn
cell
lower
percentag
dp
cell
thu
seem
sia
mucin
must
specif
regul
cell
ontogeni
fig
regard
notabl
chang
glycosyl
matur
thymocyt
demonstr
includ
vari
pattern
express
four
differ
glycosyltransferas
cell
signific
phenotyp
function
differ
among
dn
thymocyt
low
level
express
surfac
constitut
total
thymocyt
heterogen
express
sever
marker
hsa
interleukin
receptor
chain
ckit
stage
locu
undergo
rearrang
cell
undergo
product
rearrang
like
select
progress
dp
stage
character
increas
surfac
express
tcr
transit
dn
dp
stage
thymocyt
undergo
sever
round
prolifer
upregul
rearrang
stop
rearrang
begin
turn
express
sinc
full
phenotyp
character
conspicu
upregul
cell
surfac
mucin
thymocyt
matur
stage
dp
stage
establish
novel
marker
identifi
cell
commit
lineag
fig
contrast
small
increas
sp
cell
found
mucin
lineag
commit
dp
thymocyt
undergo
sever
sequenti
chang
express
hsa
thymocyt
chefcd
repres
cell
still
dp
stage
thymocyt
low
amount
either
suggest
phenotyp
matur
cell
specif
associ
earli
activ
marker
signific
fraction
cell
high
must
sp
cell
seem
lost
express
fit
expect
downregul
matur
sp
thymocyt
strong
correl
hi
tcr
hi
hsa
pattern
express
increas
surfac
suggest
oacetyl
identifi
cell
success
select
way
becom
matur
cell
fewer
sp
thymocyt
compar
peripher
rest
cell
unclear
increas
cell
occur
peripher
locat
emigr
thymu
hi
sp
cell
select
export
thymu
function
distinct
subpopul
sp
cell
report
one
studi
show
late
hi
thymocyt
function
matur
immedi
precursor
sever
assay
abl
colon
expand
peripher
lymphoid
organ
hi
lo
subset
obligatori
requir
thymic
microenviron
matur
cell
need
express
home
molecul
enter
thymic
lymphat
venul
exit
corticomedullari
junction
molecul
must
express
sp
stage
migrat
cortex
corticomedullari
junction
medulla
would
undergo
neg
select
surviv
cell
would
addit
activ
divid
express
home
receptor
probabl
influenc
local
microenviron
assum
critic
threshold
home
receptor
requir
matur
sp
cell
emigr
progress
increas
cell
surfac
sp
lineag
candid
subserv
function
correl
peripher
cell
express
exonb
indic
modif
may
marker
naiv
cell
naiv
cell
cell
memoryactiv
phenotyp
could
relev
either
specif
recircul
pattern
cell
mous
andor
recognit
costimulatori
molecul
involv
cell
activ
thu
sialic
acid
could
recogn
specif
ligand
milieu
cell
expos
modif
could
mask
recognit
underli
carbohydr
structur
cell
unknown
receptor
fig
summar
differenti
distribut
total
sialic
acid
peripher
rest
activ
cell
detect
chefcd
know
cell
surfac
marker
describ
date
specif
identifi
murin
lineag
studi
show
higher
express
specif
marker
lineag
includ
rc
isoform
epitop
depend
upon
post
translat
modif
note
dn
cell
phenotyp
cell
actual
progress
dp
stage
defin
current
data
also
note
probe
may
detect
gangliosidebound
sia
see
fig
discuss
recogn
monoclon
antibodi
isoform
suscept
glycoconjug
variou
enzym
treatment
suggest
thymocyt
glycoprotein
gangliosid
contrast
naiv
popul
mucin
major
carrier
vitro
activ
cell
appear
carri
primarili
proteaseresist
molecul
presum
gangliosid
although
substanti
decreas
mean
densiti
activ
cell
signific
differ
percentag
cell
presenc
gangliosid
rest
activ
cell
confirm
elisa
use
chefcd
studi
need
defin
precis
structur
addit
differ
level
cell
also
differ
distribut
oacetyl
glycoconjug
class
although
sialomucin
predomin
molecul
cell
seem
oacetyl
case
cell
due
quantit
differ
amount
cell
surfac
mucin
anyth
cell
surfac
densiti
two
promin
sialomucin
exon
b
isoform
cell
actual
higher
cell
rodlik
rigid
structur
mucin
molecul
cell
could
physic
restrict
bind
chefcd
oacetyl
gangliosid
closer
cell
membran
inde
unmask
effect
osgpas
trypsin
chefcd
bind
particularli
obviou
cell
unclear
two
development
close
relat
cell
type
differ
radic
sialic
acid
modif
might
due
differ
regul
oacetyltransferas
gene
express
underli
sialic
acid
linkag
mucin
molecul
cell
type
must
reemphas
olink
sialoglycoprotein
get
indiscrimin
digest
osgpas
rather
enzym
specif
recogn
cluster
sialic
acid
residu
olink
glycan
cleav
peptid
bond
close
olink
structur
thu
molecul
modifi
olink
glycosyl
resist
proteas
sugar
chain
cluster
fig
summar
concept
evolv
observ
recognit
cell
surfac
gangliosid
solubl
neighbor
cell
surfac
receptor
might
modul
express
mucinlik
structur
cell
mucin
may
may
bear
similar
carbohydr
epitop
carri
gangliosid
respect
attribut
well
demarc
cell
might
relev
biolog
although
welldefin
receptor
glycoconjug
document
mask
phenomenon
vivo
could
principl
prevent
recognit
gangliosid
rest
cell
furthermor
clear
data
activ
cell
mask
modul
state
cell
differenti
assum
might
differ
physiolog
consequ
mediat
receptor
recogn
sialic
acid
sialomucin
gangliosid
mask
cell
could
biolog
relev
regardless
biolog
signific
result
underscor
possibl
macromolecular
probe
cell
surfac
glycolipid
may
fail
detect
ligand
shield
larger
sialomucin
surfac
result
also
demonstr
two
well
character
sialomucin
cell
leukosialin
major
cell
surfac
glycoprotein
cell
also
present
cell
erythroid
myeloid
lineag
heavili
glycosyl
oglycan
attach
vari
cell
type
within
cell
base
state
differenti
differ
express
two
major
glycoform
figur
model
depict
like
differenti
distribut
sialoglycoconjug
rest
peripher
cell
sialomucin
present
cell
latter
cell
surfac
sialomucin
molecul
usual
rod
like
extend
conform
high
neg
charg
appear
prevent
chefcd
access
oacetyl
glycolipid
gangliosid
much
closer
cell
surfac
membran
osgpas
recogn
sialyl
cluster
olink
glycan
cleav
adjac
polypeptid
backbon
thu
unmask
recognit
enzymeresist
oacetyl
gangliosid
chefcd
probe
cell
speci
shown
cell
result
suggest
occur
differ
cell
regard
interest
note
express
isoform
show
invers
correl
preferenti
upregul
thymocyt
commit
sp
cell
low
sp
thymocyt
prevail
high
level
peripher
lower
level
cell
furthermor
isoform
markedli
upregul
human
cell
upon
activ
thorough
glycosyl
analysi
two
murin
isoform
need
done
one
specul
could
affect
sialic
acid
famili
high
molecular
weight
glycoprotein
variou
isoform
result
differenti
splice
exon
three
exon
code
region
rich
oglycosyl
linkag
isoform
differenti
regul
cell
receptor
signal
clear
role
carbohydr
play
neither
certain
specif
glycosyl
differ
molecul
naiv
cell
although
demonstr
exon
b
specif
isoform
possibl
may
differenti
glycosyl
cell
sialic
acid
studi
other
human
lymphoid
tissu
use
intact
influenza
c
viru
uncharacter
glycoprotein
demonstr
western
blot
deriv
human
cell
human
peripher
blood
lymphocyt
also
posit
marker
repres
g
relat
gangliosid
antibodi
bind
normal
circul
human
lymphocyt
cell
infiltr
psoriat
skin
lesion
synovi
fluid
space
rheumatoid
arthriti
patient
cutan
cell
lymphoma
major
circul
cell
dermal
lesion
also
posit
marker
stain
mous
cell
specif
antibodi
g
give
posit
result
thu
sia
appear
common
human
murin
lymphocyt
must
carri
distinct
glycolipid
interestingli
report
gangliosid
mous
cell
g
g
aris
seri
biosynthet
pathway
evid
g
member
b
seri
pathway
recent
presenc
uniqu
gangliosid
g
share
termin
trisaccharid
g
identifi
mab
mous
cell
prefer
cell
phenotyp
possibl
structur
function
homologu
g
seen
human
peripher
cell
unfortun
antibodi
current
avail
g
must
also
rememb
sialic
acid
mous
nglycolyl
group
attach
fifth
carbon
atom
instead
nacetyl
group
found
human
chang
also
influenc
recognit
antibodi
sever
report
suggest
epitop
human
cell
might
serv
altern
function
activ
pathway
cell
compartment
lesion
psoriasi
arthriti
mab
preferenti
recogn
human
cell
could
elicit
even
stronger
prolif
respons
cell
sinc
mous
peripher
cell
show
evid
studi
cell
activ
bound
solubl
form
chefcd
would
crosslink
cell
surfac
molecul
also
look
potenti
pma
induc
mitogen
cell
report
earlier
antibodi
human
cell
see
activ
could
chefcd
bind
sialomucin
block
access
glycolipid
also
effect
potenti
cell
activ
fig
sinc
chefcd
bind
cell
surfac
glycoconjug
bear
sialic
acid
might
hard
assess
effect
simultan
bind
varieti
differ
molecul
cell
activ
specif
mab
direct
murin
cell
would
need
make
valid
comparison
activ
human
cell
find
sialic
acid
mous
cell
underscor
widespread
yet
select
express
uniqu
modif
sialic
acid
sever
factor
could
regul
extent
sialic
acid
earlier
studi
demonstr
murin
erythrocyt
sialic
acid
could
regul
autosom
domin
gene
express
thu
depend
genet
background
anim
studi
group
recent
report
chines
hamster
ovari
cell
depend
avail
correct
linkag
sialic
acid
underli
sugar
chain
observ
coupl
present
find
strong
predictor
function
role
sialic
acid
remain
seen
remark
differ
sialomucin
mous
cell
might
influenc
vivo
biolog
cell
